MaxQ AI Partners with EnvoyAI to Distribute Accipio Artificial Intelligence Solutions to U.S. and E.U. Acute Care
Accipio Ix will be sold through EnvoyAI and TeraRecon's comprehensive PACS distribution channels and to the TeraRecon installed base of customers.
- Accipio Ix will be sold through EnvoyAI and TeraRecon's comprehensive PACS distribution channels and to the TeraRecon installed base of customers.
- "This partnership further accelerates the adoption of MaxQ solutions by acute care hospitals, which are TeraRecon's core customer base.
- MaxQ AI is at the forefront of transforming healthcare by empowering physicians to provide 'smarter care' with artificial intelligence (AI) clinical insights.
- By intersecting sophisticated solutions with simple implementation, EnvoyAI is enabling the broad exploration and pragmatic application of artificial intelligence in healthcare.